Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Doximity Plunges 25% Following Q4 Earnings Release

Published 2022-05-17, 04:24 p/m
Updated 2022-05-17, 04:24 p/m
© Reuters.

By Sam Boughedda

Investing.com -- Shares of Doximity Inc (NYSE:DOCS), the online networking service for medical professionals, have plunged 25% in extended trading after the company posted earnings after the close. 

The company beat profit and revenue expectations, posting adjusted earnings per share of $0.21 on revenue of $93.7 million. Revenue grew 0% year-over-year.

"We're proud to now serve over 2 million US healthcare professionals, including over 80% of US physicians and over 50% of Physician Assistants and Nurse Practitioners," said Jeff Tangney, co-founder and CEO of Doximity. "This quarter, we added scheduling to our product suite with the acquisition of Amion, and saw record use of our fax, e-signature, and telehealth tools."

Doximity also authorized a new stock repurchase program to acquire up to $70 million of its Class A common stock, beginning in the first quarter of fiscal 2023.

Despite the earnings and revenue beat, Doximity's stock plunged as it missed guidance expectations. The company sees fiscal first-quarter revenue between $88.6 million and $89.6 million, missing the $96.78 million consensus.

However, it raised its fiscal year 2023 revenue expectation to between $454 million and $458 million.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.